Product Information
- Sb-265610
SB-265610 is a selective inhibitor of the EGF receptor, which binds to the epidermal growth factor (EGF) receptor. SB-265610 prevents the binding of EGF to its receptor, thereby inhibiting tumor cell proliferation and inducing apoptosis. SB-265610 has been shown to inhibit angiogenic factors and cause an antimicrobial effect in breast cancer cells by blocking the CXCR2 chemokine receptors. It also increases the amount of time before atherosclerotic lesions progress to heart disease or cardiac death.
Chemical properties
Technical inquiry about: 3D-LIA09649 SB-265610
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
